title: [Coronary risk differences in hypertensive patients of different autonomous communities. CORONARY study].
abstract: OBJECTIVE
  Various articles describe the existence of differences in cardiovascular morbidity and mortality between different Spanish Autonomous Communities (SACs). We have intended to know if there are coherent differences in hypertensive patients cardiovascular risk.
  
  
  METHODS
  1,720 family physicians distributed in the 17 SACs as the number of inhabitants of each one selected 5 consecutive patients maximum within a period of 2 months, with blood pressure > or = 140/90 mmHg and at least another coronary risk factor. In 6,775 of 7,469 patients (51% males), the risk of a coronary event (CE) in the next 10 years according to Framingham equation and the risk of fatal cardiovascular event (RCV) according to Score formula were calculated.
  
  
  RESULTS
  CE calculated in the group of patients in primary prevention (and without diabetes) in northern SACs (Cantábrico) was 18.8%, and 20.5% in south-east SACs (Mediterranean) (p < 0.0001). In addition, CE in secondary prevention was 26.1% in northern SACs and 28.6% in south-east SACs (p < 0.0001). The differences remained upon considering diabetics in primary prevention. There were no significant differences, however, in the risk of cardiovascular death (Score) between both areas, being 8.9% in the north and 8.8% in the south-east.
  
  
  CONCLUSIONS
  Our study demonstrates that coronary risk is increased in hypertensive populations of south east SACs with respect to SACs of the north and to national average, while the risk of suffering a fatal cardiovascular event is not different.
authors.affiliation: Hospital Universitario La Fe, Valencia. hernandiz_amp@gva.es
authors.forename: J
authors.initials: J
authors.lastname: Cosín Aguilar
authors.forename: L
authors.initials: L
authors.lastname: Rodríguez Padial
authors.forename: J L
authors.initials: JL
authors.lastname: Zamorano Gómez
authors.forename: R
authors.initials: R
authors.lastname: Arístegui Urrestarazu
authors.forename: B
authors.initials: B
authors.lastname: Armada Peláez
authors.forename: A
authors.initials: A
authors.lastname: Hernándiz Martínez
authors.forename: A
authors.initials: A
authors.lastname: Aguilar Llopis
authors.forename: X
authors.initials: X
authors.lastname: Masramón Morell
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D016001:Confidence Intervals; D003327:Coronary Disease / Q000453:epidemiology* / Q000517:prevention & control; D005260:Female; D005843:Geography; D006305:Health Status Indicators; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011322:Primary Prevention; D018570:Risk Assessment; D012307:Risk Factors; D013030:Spain / Q000453:epidemiology
chemical_list: D000959:Antihypertensive Agents